Frontier Capital Management CO LLC Bridge Bio Pharma, Inc. Transaction History
Frontier Capital Management CO LLC
- $9.73 Billion
- Q4 2024
A detailed history of Frontier Capital Management CO LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 1,075,858 shares of BBIO stock, worth $39.6 Million. This represents 0.3% of its overall portfolio holdings.
Number of Shares
1,075,858
Previous 503,162
113.82%
Holding current value
$39.6 Million
Previous $12.8 Million
130.45%
% of portfolio
0.3%
Previous 0.13%
Shares
4 transactions
Others Institutions Holding BBIO
# of Institutions
321Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$931 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$926 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$556 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$459 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$228 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.46B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...